Related references
Note: Only part of the references are listed.PLECANATIDE AND DOLCANATIDE, GUANYLATE CYCLASE-C AGONISTS, ATTENUATE PARACELLULAR PERMEABILITY AND ENHANCE NORMAL LOCALIZATION OF TIGHT JUNCTIONAL PROTEINS TO MAINTAIN INTESTINAL BARRIER FUNCTION
Anusha Thadi et al.
GASTROENTEROLOGY (2017)
Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation
Michael DeMicco et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2017)
The Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Chronic Idiopathic Constipation (BURDEN-CIC) Study: Results of an Online Questionnaire
Lucinda A. Harris et al.
ADVANCES IN THERAPY (2017)
Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome
Gregory S. Sayuk et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation
Philip B. Miner et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation
L. Neri et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2016)
Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan
Motoyori Kanazawa et al.
BIOPSYCHOSOCIAL MEDICINE (2016)
The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing Symptoms, Care Seeking, and Disease Burden
Joel J. Heidelbaugh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Guanylate Cyclase C Agonists: Emerging Gastrointestinal Therapies and Actions
Michael Camilleri
GASTROENTEROLOGY (2015)
Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases
A. Jarmuz et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2015)
Reduced E-cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS
E. Wilcz-Villega et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
Tight junctions and IBS - the link between epithelial permeability, low-grade inflammation, and symptom generation?
T. Piche
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
Emerging receptor target in the pharmacotherapy of irritable bowel syndrome with constipation
L. Ashley Blackshaw et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Rebecca M. Lovell et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Intestinal barrier function in health and gastrointestinal disease
M. Camilleri et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
The Expression and the Cellular Distribution of the Tight Junction Proteins Are Altered in Irritable Bowel Syndrome Patients With Differences According to the Disease Subtype
Nathalie Bertiaux-Vandaele et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Uroguanylin Regulates Net Fluid Secretion via the NHE2 Isoform of the Na+/H+ Exchanger in an Intestinal Cellular Model
Roxana Toriano et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2011)
Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome
Marco DiBonaventura et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Loss of Guanylyl Cyclase C (GCC) Signaling Leads to Dysfunctional Intestinal Barrier
Xiaonan Han et al.
PLOS ONE (2011)
Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit
Robert W. Busby et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
International Survey of Patients With IBS Symptom Features and Their Severity, Health Status, Treatments, and Risk Taking to Achieve Clinical Benefit
Douglas A. Drossman et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact
APS Hungin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
The usual medical care for irritable bowel syndrome
WE Whitehead et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Irritable bowel syndrome medications side effects survey
A Lembo
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Share Paper
